JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (30) Citing Articles via Google Scholar Google Scholar Articles by Neff, T. A. Articles by Stocker, R. Search for Related Content PubMed PubMed Citation Articles by Neff, T. A. Articles by Stocker, R. Related Collections Blood Neuroanesthesia Trauma

---

NEUROSURGICAL ANESTHESIA

Repetitive Large-Dose Infusion of the Novel Hydroxyethyl Starch 130/0.4 in Patients with Severe Head Injury

Thomas A. Neff, MD^*, Martin Doelberg, PhD, Cornelius Jungheinrich, MD, Andrea Sauerland, Donat R. Spahn, MD^*, and Reto Stocker, MD

*Institute of Anesthesiology and Division of Surgical Intensive Care, University Hospital, Zurich, Switzerland; Clinical Research Department, Fresenius Kabi, Bad Homburg, Germany

Address correspondence and reprint requests to Thomas A. Neff, MD, University of Michigan Medical School, Department of Pathology, 7526 MSRB 1/0602, 1150 West Medical Center Dr., Ann Arbor, MI 48109. Address e-mail to thomas.neff{at}gmx.net

In this prospective, controlled, randomized, single-center study, we investigated the safety of repetitive large-dose infusion of a novel hydroxyethyl starch solution (6% HES 130/0.4) in cranio-cerebral trauma patients. Patients were randomized to receive either HES 130/0.4 (n = 16) at repetitive doses of up to 70 mL · kg^-1 · d^-1 (which is the largest HES dose reported in the literature) or the control HES 200/0.5 (n = 15) up to its approved dose limit of 33 mL · kg^-1 · d^-1 followed by human albumin up to a total dose (HES 200/0.5 + albumin) of 70 mL · kg^-1 · d^-1. We found no differences between groups in mortality, renal function, bleeding complications, and use of blood products. There were also no major differences in coagulation variables. However, at some time points, factor VIII, von Willebrand factor, and ristocetin cofactor were higher in the HES 130/0.4 group despite the large HES doses administered. We conclude that HES 130/0.4 can safely be used in critically ill head trauma patients over several days at doses of up to 70 mL · kg^-1 · d^-1.

IMPLICATIONS: There are concerns that infusion of certain hydroxyethyl starch (HES) types for plasma volume expansion may influence coagulation and renal function. We investigated the safety of the novel HES 130/0.4 in patients with severe cranio-cerebral trauma. The repetitive HES doses administered in this study are the largest reported in the literature.

This article has been cited by other articles:

				V. Blasco, M. Leone, F. Antonini, A. Geissler, J. Albanese, and C. Martin Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation Br. J. Anaesth., April 1, 2008; 100(4): 504 - 508. [Abstract] [Full Text] [PDF]

				G. H. Mills Hydroxyethyl starch: does our choice of colloid prevent or add to renal impairment? Br. J. Anaesth., February 1, 2007; 98(2): 157 - 159. [Full Text] [PDF]

				Y. Sakr, D. Payen, K. Reinhart, F. S. Sipmann, E. Zavala, J. Bewley, G. Marx, and J.-L. Vincent Effects of hydroxyethyl starch administration on renal function in critically ill patients Br. J. Anaesth., February 1, 2007; 98(2): 216 - 224. [Abstract] [Full Text] [PDF]

				P. Van der Linden and B. E. Ickx The effects of colloid solutions on hemostasis: [Les effets des solutions colloides sur l'hemostase] Can J Anesth, June 1, 2006; 53(6_suppl): S30 - S39. [Abstract] [Full Text] [PDF]

				T. A. Neff, L. Fischler, M. Mark, R. Stocker, and W. H. Reinhart The Influence of Two Different Hydroxyethyl Starch Solutions (6% HES 130/0.4 and 200/0.5) on Blood Viscosity Anesth. Analg., June 1, 2005; 100(6): 1773 - 1780. [Abstract] [Full Text] [PDF]

				R. Arellano, B. S. Gan, M. J. Salpeter, E. Yeo, S. McCluskey, R. Pinto, J. Irish, D. C. Ross, D. J. Doyle, J. Parkin, et al. A Triple-Blinded Randomized Trial Comparing the Hemostatic Effects of Large-Dose 10% Hydroxyethyl Starch 264/0.45 Versus 5% Albumin During Major Reconstructive Surgery Anesth. Analg., June 1, 2005; 100(6): 1846 - 1853. [Abstract] [Full Text] [PDF]

				G. R. Haynes, K. E. Berman, T. A. Neff, R. Stocker, D. R. Spahn, J. E. Barone, W. A. Primack, K. Estes, E. C. Walter, R. Wendorf, et al. Fluid Resuscitation in the Intensive Care Unit N. Engl. J. Med., October 28, 2004; 351(18): 1905 - 1908. [Full Text] [PDF]

				G. R. Haynes, T. A. Neff, R. Stocker, and D. R. Spahn Is Hydroxyethyl Starch Safe in Brain Injury? * Response Anesth. Analg., August 1, 2004; 99(2): 620 - 622. [Full Text] [PDF]

Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999